Lamotrin-Mepha 5 mg, Tabletten - 60 Tablette(n) Swissmedic Key 57137006 Registration Holder Mepha Pharma AG Name Lamotrin-Mepha 5 mg, Tabletten Date of registration 14.07.2005 Original/Generic Generic Introduction of Sequence 14.07.2005 ATC-Classification Lamotrigine (N03AX09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.07.10. Show package size 60 Tablette(n) Index Therapeuticus (Swissmedic) 01.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1.70 Limitation No Deductible 10 % Consumer price 11.05 Feedback FB Daily cost GTIN 7680571370066 Medication Code Synthetika Pharmacode 3013546 Disponibility
Composition lamotriginum 5 mg, calcii carbonas, sorbitolum 15.16 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, glyceroli dibehenas, silica colloidalis anhydrica, aromatica, saccharinum natricum corresp. natrium 0.168 mg pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Lamotrigine 5 mg
BAG: Active Agent Dose Lamotrigine 5 mg
Inactive agents Dose Aromatica Calcium Carbonate Cellulosum Microcristallinum Silicificatum Crospovidonum Glyceroli Dibehenas Maydis Amylum Pro Compresso Saccharinum Natricum Silica Colloidalis Anhydrica Sorbitol 15.16 mg Talcum
Source Data was imported : 05.04.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
